Previous close | 1.8300 |
Open | 1.3000 |
Bid | 0.9000 |
Ask | 1.0900 |
Strike | 340.00 |
Expiry date | 2024-06-21 |
Day's range | 1.0800 - 1.3000 |
Contract range | N/A |
Volume | |
Open interest | 1.51k |
(Bloomberg) -- Investors who may have missed out on the blistering rally in Eli Lilly & Co. and Novo Nordisk A/S are once again taking a chance with Amgen Inc.Most Read from BloombergTruce Talks Drag as Hamas Hits Israel Crossing in Deadly AttackBuffett Praises Apple After Trimming It, Drops Paramount StakeTreasury Rally Risks Running Into a $125 Billion Brick WallFrance’s Macron Calls for Reset of Economic Ties With ChinaLamborghini Bros No More: Crypto Is Creating a New Wealth EffectThe shares
Amgen ( NASDAQ:AMGN ) First Quarter 2024 Results Key Financial Results Revenue: US$7.45b (up 22% from 1Q 2023). Net...
Insightful Analysis of Amgen Inc's Strengths, Weaknesses, Opportunities, and Threats